Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Rare mutations can significantly increase risk factor for heart disease

17.08.2004


Certain rare gene mutations can contribute significantly to low levels of a beneficial form of cholesterol in the blood, researchers have found. Low levels of this cholesterol, known as high-density lipoprotein (HDL), are a major risk factor for heart disease.



Gene mutations previously known to affect HDL levels had small effects individually, and it was thought many such mutations needed to accumulate before HDL levels were significantly reduced. The new finding, however, demonstrates that mutations in a few genes can be sufficient to affect blood cholesterol levels. According to the researchers, the strategy used in this study can be generalized to analyze the role of rare variations in candidate genes in other clinically important complex human traits.

Led by Howard Hughes Medical Institute investigator Helen H. Hobbs, who is at the University of Texas Southwestern Medical Center at Dallas, the researchers published their findings in the August 6, 2004, issue of the journal Science. Hobbs’ colleagues from the University of Texas Southwestern and the University of Ottawa Heart Institute were coauthors on the paper.


HDL is important for preventing heart disease because it transports cholesterol in the blood back to the liver, leading to its removal from the body and preventing its buildup on artery walls. The level of HDL in the blood is a complex trait, influenced to varying degrees by many genes, as well as environmental and lifestyle factors such as diet and exercise.

Previously, researchers believed that the genetic component of this trait depended primarily on the cumulative effect of many common genetic variations, each of which influenced HDL levels in a small way. However, rare variations with stronger effects are also likely to be involved. "What we wanted to know," Hobbs said, "was how much do single gene defects with major effects contribute to complex traits?"

Although mutations with such a strong effect on overall HDL levels may be rare individually, the researchers said, collectively, mutations of this type might be common enough to contribute to the variation seen throughout the population.

To determine the influence of rare mutations, the scientists relied on data from individuals enrolled in a study run by Hobbs, known as the Dallas Heart Study. Hobbs and her colleagues designed the study in 1999 to examine the biological and social causes of ethnic disparities in cardiovascular disease. Through this study, they have collected extensive data and samples from approximately 3,000 multiethnic participants through health surveys, blood and urine samples, and imaging studies.

The usual approach to identifying relevant genes, Hobbs said, is for researchers to identify a mutation in individuals with low levels of HDL and look for the frequency of that mutation in the general population. In this study, however, the researchers increased the likelihood of detecting gene mutations that significantly influenced the final trait by focusing on individuals at the extreme ends of the spectrum of HDL levels. Using 128 subjects from the Dallas Heart Study, they compared the genes of those with HDL levels in the lowest five percent of the population to those whose HDL levels fell in the top five percent.

"The value of the approach," Hobbs said, "is that you not only get the common variations, but you can address whether individual rare genotypes also contribute to the phenotype."

In their search for genetic differences between the two groups, the researchers focused on three genes that, when defective, had been implicated in rare forms of HDL deficiency. These were genes coding for proteins that play critical roles in cholesterol metabolism and transport, known as apoplipoprotein A1 (APOA1), adenosine triphosphate binding cassette transporter A1 (ABCA1), and lecithin cholesterol acyltransferase (LCAT). Individuals with two defective copies of any of these genes have virtually no HDL circulating in their blood, whereas individuals with only one functional copy of the gene have about half the normal plasma level of HDL.

The researchers sequenced the three genes and looked for changes in the DNA that would alter the resulting protein. Such variations were found in 16 percent of the individuals with low HDL levels, whereas they occurred in only two percent of those with high HDL.

To ensure that these differences were specific to mutations that might affect HDL levels and exclude the possibility that mutations in general were occurring more frequently in one group, the researchers also compared the frequency of non-synonymous sequence variations – those that exist only at the DNA level and would not affect the protein. They found these to be similar in the groups with high and low HDL levels.

Additionally, they confirmed their results in an independent population of patients and examined cells from the individuals in that analysis to show that sequence variants in the low-HDL group were functionally important.

According to the researchers, the results of their study provide direct evidence that rare variations in DNA significantly affect levels of HDL in the blood. A better understanding of the DNA sequence variations that contribute to low levels of HDL will not only help researchers understand the disease, but, with further study, may also help in the identification of new treatment targets and diagnostic tests.

This new understanding of the role of rare genes is just one piece of the complex network of factors that shape heart disease risk, but according to Hobbs, the Dallas Heart Study provides an invaluable means to further examine those factors and their interplay. "We’ve developed a carefully phenotyped population, with information not just on lipoprotein levels, but also drugs, weight, family history, etcetera," she said, "so we can now go back and look at how those things together may have shaped these individuals’ risks."

Jennifer Michalowski | EurekAlert!
Further information:
http://www.hhmi.org

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>